• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国与瑞典成年人高血压患病率、知晓率、治疗率和控制率的性别差异及其决定因素。

Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden.

机构信息

Department of Epidemiology and Global Health, Faculty of Medicine, Umeå University, 90187, Umeå, Sweden.

Global Public Health, School of Public Health and Community Medicine, Institution of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390, Gothenburg, Sweden.

出版信息

BMC Public Health. 2020 Nov 23;20(1):1763. doi: 10.1186/s12889-020-09862-4.

DOI:10.1186/s12889-020-09862-4
PMID:33228600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685617/
Abstract

BACKGROUND

Failure to promote early detection and better management of hypertension will contribute to the increasing burden of cardiovascular diseases. This study aims to assess the gender differences in the prevalence, awareness, treatment and control of hypertension, together with its associated factors, in China and Sweden.

METHODS

We used data from two cross-sectional studies: the Västerbotten Intervention Program in northern Sweden (n = 25,511) and the Shanghai survey in eastern China (n = 25,356). We employed multivariable logistic regression to examine the socio-demographics, lifestyle behaviours, and biological factors associated with the prevalence, awareness, treatment and control of hypertension.

RESULTS

Men had a higher prevalence of hypertension (43% in Sweden, 39% in China) than their female counterparts (29 and 36%, respectively). In Sweden, men were less aware of, less treated for, and had less control over their hypertension than women. Chinese men were more aware of, had similar levels of treatment for, and had less control over their hypertension compared to women. Awareness and control of hypertension was lower in China compared to Sweden. Only 33 and 38% of hypertensive Chinese men and women who were treated reached the treatment goals, compared with a respective 48 and 59% in Sweden. Old age, impaired glucose tolerance or diabetes, a family history of hypertension or cardiovascular diseases, low physical activity and overweight or obesity were found to increase the odds of hypertension and its diagnosis.

CONCLUSIONS

This study shows the age and gender differences in the prevalence, awareness, treatment and control of hypertension among adults in China and Sweden. Multisectoral intervention should be developed to address the increasing burden of sedentary lifestyle, overweight and obesity and diabetes, all of which are linked to the prevention and control of hypertension. Development and implementation of the gender- and context-specific intervention for the prevention and control of hypertension facilitates understanding with regard to the implementation barriers and facilitators.

摘要

背景

未能促进高血压的早期发现和更好的管理,将导致心血管疾病负担不断增加。本研究旨在评估中国和瑞典的高血压流行率、知晓率、治疗率和控制率的性别差异,以及其相关因素。

方法

我们使用了来自两项横断面研究的数据:瑞典北部的维斯特博滕干预项目(n=25511)和中国东部的上海调查(n=25356)。我们采用多变量逻辑回归来检查与高血压流行率、知晓率、治疗率和控制率相关的社会人口统计学、生活方式行为和生物学因素。

结果

男性的高血压患病率(瑞典为 43%,中国为 39%)高于女性(分别为 29%和 36%)。在瑞典,男性对高血压的知晓率、治疗率和控制率均低于女性。中国男性对高血压的知晓率较高,治疗率相似,对高血压的控制率较低。与瑞典相比,中国高血压的知晓率和控制率较低。仅分别有 33%和 38%接受治疗的中国高血压男性和女性达到了治疗目标,而瑞典相应的比例分别为 48%和 59%。年龄较大、糖耐量受损或糖尿病、高血压或心血管疾病家族史、体力活动水平低以及超重或肥胖,均增加了高血压及其诊断的可能性。

结论

本研究显示了中国和瑞典成年人中高血压的流行率、知晓率、治疗率和控制率存在年龄和性别差异。应制定多部门干预措施,以应对久坐不动的生活方式、超重和肥胖以及糖尿病的增加,这些都与高血压的预防和控制有关。制定和实施针对高血压预防和控制的性别和具体环境的干预措施,有助于了解实施障碍和促进因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/90a82e42280d/12889_2020_9862_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/f592da011dd6/12889_2020_9862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/a3594137ab48/12889_2020_9862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/90f2bee9d7d4/12889_2020_9862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/90a82e42280d/12889_2020_9862_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/f592da011dd6/12889_2020_9862_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/a3594137ab48/12889_2020_9862_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/90f2bee9d7d4/12889_2020_9862_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/7685617/90a82e42280d/12889_2020_9862_Fig4_HTML.jpg

相似文献

1
Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden.中国与瑞典成年人高血压患病率、知晓率、治疗率和控制率的性别差异及其决定因素。
BMC Public Health. 2020 Nov 23;20(1):1763. doi: 10.1186/s12889-020-09862-4.
2
Trends of blood pressure levels and management in Västerbotten County, Sweden, during 1990-2010.瑞典韦斯特博滕省 1990-2010 年期间血压水平和管理趋势。
Glob Health Action. 2012;5. doi: 10.3402/gha.v5i0.18195. Epub 2012 Jul 30.
3
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).中国高血压的患病率、知晓率、治疗率和控制率:一项基于人群筛查研究的 170 万成年人数据(中国高血压调查)。
Lancet. 2017 Dec 9;390(10112):2549-2558. doi: 10.1016/S0140-6736(17)32478-9. Epub 2017 Nov 5.
4
Burden of hypertension in China: A nationally representative survey of 174,621 adults.中国高血压负担:一项对174,621名成年人的全国代表性调查。
Int J Cardiol. 2017 Jan 15;227:516-523. doi: 10.1016/j.ijcard.2016.10.110. Epub 2016 Nov 2.
5
Prevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg project.高血压的患病率、知晓率、治疗率和控制率:在 Skaraborg 项目中遵循三分法则。
Scand J Prim Health Care. 2012 Jun;30(2):88-94. doi: 10.3109/02813432.2012.684207.
6
[Trends in prevalence, awareness, treatment and control of hypertension in middle-aged Chinese population].[中国中年人群高血压患病率、知晓率、治疗率及控制率的变化趋势]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 May;25(5):407-11.
7
[Prevalence, awareness, treatment and control of hypertension in Chinese adults].中国成年人高血压的患病率、知晓率、治疗率及控制率
Zhonghua Yu Fang Yi Xue Za Zhi. 2003 Mar;37(2):84-9.
8
Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey.中国 3579 名高血压成年人中与高血压知晓率、治疗率和控制率相关的因素:来自中国健康与营养调查的数据。
BMC Public Health. 2021 Mar 1;21(1):423. doi: 10.1186/s12889-021-10417-4.
9
Prevalence, awareness, treatment, control and socio demographic determinants of hypertension in Malaysian adults.马来西亚成年人高血压的患病率、知晓率、治疗率、控制率及社会人口学决定因素
BMC Public Health. 2016 Apr 21;16:351. doi: 10.1186/s12889-016-3008-y.
10
A cross-sectional study of the prevalence, awareness, treatment and control of hypertension in Shenzhen, China.中国深圳高血压患病率、知晓率、治疗率及控制率的横断面研究。
BMJ Open. 2017 Jun 15;7(6):e015206. doi: 10.1136/bmjopen-2016-015206.

引用本文的文献

1
Hypertension Cascade Across Three Healthcare Systems and in Relation to the Level of Implementation of the Integrated Care Package.三个医疗系统中的高血压级联反应及其与综合护理包实施水平的关系。
Int J Integr Care. 2025 Aug 22;25(3):22. doi: 10.5334/ijic.8921. eCollection 2025 Jul-Sep.
2
Community-Based Evaluation of Hypertension Awareness and Knowledge Among Underserved Bateyes in the Dominican Republic.多米尼加共和国服务欠缺的巴特耶人群中高血压知晓率和知识的社区评估
Clin Med Insights Cardiol. 2025 Jun 24;19:11795468251350224. doi: 10.1177/11795468251350224. eCollection 2025.
3
Significant interplay of BMI and Anthropometric Profile on Gender-Specific Health Indicators.

本文引用的文献

1
Cohort profile: protocol and baseline survey for the Shanghai Suburban Adult Cohort and Biobank (SSACB) study.队列研究简介:上海郊区成人队列和生物库(SSACB)研究的方案和基线调查。
BMJ Open. 2020 Jul 8;10(7):e035430. doi: 10.1136/bmjopen-2019-035430.
2
Quality of primary health care in China: challenges and recommendations.中国基层医疗保健的质量:挑战与建议。
Lancet. 2020 Jun 6;395(10239):1802-1812. doi: 10.1016/S0140-6736(20)30122-7.
3
Association of Physician Education and Feedback on Hypertension Management With Patient Blood Pressure and Hypertension Control.
体重指数(BMI)与人体测量学特征在特定性别健康指标上的显著相互作用。
Pak J Med Sci. 2025 May;41(5):1352-1359. doi: 10.12669/pjms.41.5.11780.
4
Development and Validation of a Hypertension Risk Prediction Model Based on Particle Swarm Optimization-Support Vector Machine.基于粒子群优化-支持向量机的高血压风险预测模型的开发与验证
Bioengineering (Basel). 2025 Feb 26;12(3):238. doi: 10.3390/bioengineering12030238.
5
A Study on Prevalence and Factors Affecting Hypertension in an Iranian Population: Results from the Fasa Cohort Study.伊朗人群高血压患病率及影响因素研究:法萨队列研究结果
Med J Islam Repub Iran. 2024 Oct 23;38:123. doi: 10.47176/mjiri.38.123. eCollection 2024.
6
Hypertension awareness, treatment, control, and prognosis: insights from the sub-cohort of China PEACE million persons project.高血压的知晓、治疗、控制及预后:来自中国百万人群心脑血管病队列研究子队列的见解
Hypertens Res. 2025 Mar;48(3):1012-1023. doi: 10.1038/s41440-024-02037-3. Epub 2024 Dec 5.
7
Differences in sex and age response to single pill combination based antihypertensive therapy reflecting in blood pressure and arterial stiffness.性别和年龄对单片复方降压治疗反应的差异体现在血压和动脉僵硬度方面。
J Hypertens. 2025 Mar 1;43(3):387-396. doi: 10.1097/HJH.0000000000003901. Epub 2024 Nov 7.
8
Prevalence and Associated Factors of Uncontrolled Hypertension Among Patients Attending Primary Healthcare Centers in Riyadh, Saudi Arabia.沙特阿拉伯利雅得市基层医疗中心就诊患者中未控制高血压的患病率及相关因素
Cureus. 2024 Jul 17;16(7):e64783. doi: 10.7759/cureus.64783. eCollection 2024 Jul.
9
Awareness of having hypertension, diabetes and dyslipidaemia among US adults: The 2011-2018 NHANES data.美国成年人中高血压、糖尿病和血脂异常的知晓情况:2011 - 2018年美国国家健康与营养检查调查(NHANES)数据
Scand J Public Health. 2025 Jun;53(4):391-399. doi: 10.1177/14034948241247612. Epub 2024 Apr 28.
10
Prevalence and Clustering of Cardiovascular Disease Risk Factors among Adults Along the Lancang-Mekong River: A Cross-Sectional Study from Low- and Middle-Income Countries.澜湄流域成年人心血管疾病危险因素的流行情况及聚集性:来自中低收入国家的横断面研究。
Glob Heart. 2024 Apr 17;19(1):35. doi: 10.5334/gh.1319. eCollection 2024.
高血压管理中医生教育和反馈对患者血压及高血压控制的影响。
JAMA Netw Open. 2020 Jan 3;3(1):e1918625. doi: 10.1001/jamanetworkopen.2019.18625.
4
Prevalence and the Association of Body Mass Index and Other Risk Factors with Prediabetes and Type 2 Diabetes Among 50,867 Adults in China and Sweden: A Cross-Sectional Study.中国和瑞典50867名成年人中体重指数及其他危险因素与糖尿病前期和2型糖尿病的患病率及关联:一项横断面研究
Diabetes Ther. 2019 Dec;10(6):2061-2077. doi: 10.1007/s13300-019-00690-3. Epub 2019 Sep 11.
5
Health literacy and health outcomes in hypertension: An integrative review.高血压患者的健康素养与健康结局:一项综合综述
Int J Nurs Sci. 2018 Jun 9;5(3):301-309. doi: 10.1016/j.ijnss.2018.06.001. eCollection 2018 Jul 10.
6
Association between anthropometric indicators of obesity and cardiovascular risk factors among adults in Shanghai, China.中国上海成年人肥胖的人体测量学指标与心血管危险因素的关系。
BMC Public Health. 2019 Aug 2;19(1):1035. doi: 10.1186/s12889-019-7366-0.
7
Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses.中国高血压知晓率、治疗率和控制率的性别差异:系统评价和荟萃分析。
Hypertens Res. 2019 Feb;42(2):273-283. doi: 10.1038/s41440-018-0154-x. Epub 2018 Dec 6.
8
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
9
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
10
Interventions to improve medication adherence among Chinese patients with hypertension: a systematic review and meta-analysis of randomized controlled trails.改善中国高血压患者药物依从性的干预措施:随机对照试验的系统评价和荟萃分析
Int J Pharm Pract. 2018 Aug;26(4):291-301. doi: 10.1111/ijpp.12452. Epub 2018 Apr 25.